Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Scynexis (SCYX) Gains from Investment Securities: 2013-2024

Historic Gains from Investment Securities for Scynexis (SCYX) over the last 10 years, with Dec 2024 value amounting to $2.9 million.

  • Scynexis' Gains from Investment Securities rose 153.35% to $3.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.6 million, marking a year-over-year increase of 130.19%. This contributed to the annual value of $2.9 million for FY2024, which is 55.53% up from last year.
  • Scynexis' Gains from Investment Securities amounted to $2.9 million in FY2024, which was up 55.53% from $1.9 million recorded in FY2023.
  • Scynexis' Gains from Investment Securities' 5-year high stood at $5.2 million during FY2020, with a 5-year trough of $1.5 million in FY2021.
  • For the 3-year period, Scynexis' Gains from Investment Securities averaged around $2.2 million, with its median value being $1.9 million (2023).
  • In the last 5 years, Scynexis' Gains from Investment Securities plummeted by 70.42% in 2021 and then soared by 55.53% in 2024.
  • Over the past 5 years, Scynexis' Gains from Investment Securities (MRY) stood at $5.2 million in 2020, then tumbled by 70.42% to $1.5 million in 2021, then rose by 12.85% to $1.7 million in 2022, then grew by 7.33% to $1.9 million in 2023, then skyrocketed by 55.53% to $2.9 million in 2024.
  • Its Gains from Investment Securities stands at $2.9 million for FY2024, versus $1.9 million for FY2023 and $1.7 million for FY2022.